ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.625,77
0,05%
S&P 500
5.427,86
-0,11%
US Dollar vs BRL
5,3772
0,26%
Bitcoin
65.443,99
-1,97%
Brent Oil
82,35
0,46%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Theratechnologies Inc. (MM) (THER)

  7. Theratechnologies Inc. (MM) (THER) Notícias

THER

Therasense (THER)

Theratechnologies Inc. (MM)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:THER
DataHoraFonteTítuloCódigoCompanhia
03/12/202112:45GlobeNewswire Inc.Theratechnologies Europe riceve il premio "Innovation Business Award" nella categoria "Scienza e Salute" dall'ANGI, associazione Nazionale Giovani Innovatori per ibalizumabNASDAQ:THERTheratechnologies Inc. (MM)
26/10/202103:00GlobeNewswire Inc.THERATECHNOLOGIES ANNUNCIA IN ITALIA UN ACCORDO PER LA RIMBORSABILITA’ DI TROGARZO® PER I PAZIENTI CON INFEZIONE DA VIRUS HIV-1 MULTIRESISTENTENASDAQ:THERTheratechnologies Inc. (MM)
26/10/202103:00GlobeNewswire Inc.Theratechnologies Announces Reimbursement Agreement in Italy for Trogarzo® for Eligible Patients With Multi-Drug Resistant HIV-1NASDAQ:THERTheratechnologies Inc. (MM)
26/10/202103:00GlobeNewswire Inc.Theratechnologies annonce un accord de remboursement en Italie pour Trogarzo® pour les patients admissibles présentant une infection par le VIH-1 multirésistanteNASDAQ:THERTheratechnologies Inc. (MM)
30/09/202017:01GlobeNewswire Inc.Theratechnologies to Present at the H.C. Wainwright 4th Annual NASH Investor Conference on October 5NASDAQ:THERTheratechnologies Inc. (MM)
30/09/202017:01GlobeNewswire Inc.Theratechnologies fera une présentation au H.C. Wainwright 4th Annual NASH Investor Conference le 5 octobre 2020NASDAQ:THERTheratechnologies Inc. (MM)
10/09/202003:00GlobeNewswire Inc.Theratechnologies annonce le lancement de Trogarzo(MD) en AllemagneNASDAQ:THERTheratechnologies Inc. (MM)
10/09/202003:00GlobeNewswire Inc.Theratechnologies Announces Launch of Trogarzo® in GermanyNASDAQ:THERTheratechnologies Inc. (MM)
07/11/201909:30GlobeNewswire Inc.Trogarzo® Remains Effective Close to a Decade After Treatment InitiationNASDAQ:THERTheratechnologies Inc. (MM)
07/11/201909:30GlobeNewswire Inc.Trogarzo(MD) demeure efficace près d’une décennie après le début du traitementNASDAQ:THERTheratechnologies Inc. (MM)
27/09/201909:28GlobeNewswire Inc.Europäische Kommission erteilt Zulassung für Trogarzo®NASDAQ:THERTheratechnologies Inc. (MM)
26/09/201915:13GlobeNewswire Inc.La Commission européenne approuve Trogarzo(MD)NASDAQ:THERTheratechnologies Inc. (MM)
26/09/201915:13GlobeNewswire Inc.European Commission Approves Trogarzo®NASDAQ:THERTheratechnologies Inc. (MM)
01/02/201312:03Edgar (US Regulatory)Certification of No Change in Definitive Materials. (497j)NASDAQ:THERTheratechnologies Inc. (MM)
01/02/201312:02Edgar (US Regulatory)Amended Annual Report (foreign Private Issuer) (40-f/a)NASDAQ:THERTheratechnologies Inc. (MM)
29/01/201313:55MarketwiredTheratechnologies Secures US Patent for its Novel Peptide TH1173NASDAQ:THERTheratechnologies Inc. (MM)
28/01/201317:34Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:THERTheratechnologies Inc. (MM)
28/01/201312:33Edgar (US Regulatory)Registration of Securities by Certain Investment Companies. Declaration of Election Rule 24f-2 Notice (24f-2nt)NASDAQ:THERTheratechnologies Inc. (MM)
28/01/201312:33Edgar (US Regulatory)(25)NASDAQ:THERTheratechnologies Inc. (MM)
21/01/201309:53MarketwiredTheratechnologies Inc.: FDA Approves Alternative Storage Conditions for EGRIFTA(TM)NASDAQ:THERTheratechnologies Inc. (MM)
14/01/201314:44Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:THERTheratechnologies Inc. (MM)
14/01/201314:44Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:THERTheratechnologies Inc. (MM)
14/01/201309:54MarketwiredTheratechnologies Announces Intent to Voluntarily Delist from NASDAQNASDAQ:THERTheratechnologies Inc. (MM)
30/10/201209:53MarketwiredTheratechnologies Inc.: Revenue Growth and Expenditure Control at the Core of Revised Business PlanNASDAQ:THERTheratechnologies Inc. (MM)
29/10/201209:30MarketwiredTheratechnologies to Host Conference CallNASDAQ:THERTheratechnologies Inc. (MM)
11/10/201219:13MarketwiredTheratechnologies Announces Departure of President and Chief Executive OfficerNASDAQ:THERTheratechnologies Inc. (MM)
11/10/201217:45MarketwiredTheratechnologies Announces Financial Results for Third Quarter of 2012NASDAQ:THERTheratechnologies Inc. (MM)
11/10/201211:00MarketwiredREMINDER/Theratechnologies to Announce Financial Results for Third Quarter of 2012NASDAQ:THERTheratechnologies Inc. (MM)
10/10/201208:30MarketwiredTheratechnologies Provides Follow-Up Regulatory Update on TesamorelinNASDAQ:THERTheratechnologies Inc. (MM)
03/10/201216:08MarketwiredTheratechnologies to Announce Financial Results for Third Quarter of 2012NASDAQ:THERTheratechnologies Inc. (MM)
 Apresentando as notícias mais relevantes sobre:NASDAQ:THER

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
TELB4
TELEBRAS PN
BOV
PRIO3
PETRORIO ON
BOV
HAGA3
HAGA ON
BOV
COGN3
COGNA ON
BOV
AMAR3
LOJAS MARISA ON
BOV
OIBR3
OI ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
AMER3
Americanas ON
BOV
TECN3
TECHNOS ON
BOV
DASA3
DASA ON
BOV
RRRP3
3R Petroleum Oleo E Gas ... ON
BOV
IRBR3
IRB BRASIL ON
BOV
FNAM11
Fundo Invest Amazonia Fi...
BOV
RCSL4
RECRUSUL PN
BOV
POMO4
MARCOPOLO PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados